|
|
Blood, 15 September 2008, Vol. 112, No. 6, pp. 2340-2352.
Prepublished online as a Blood First Edition Paper on July 10, 2008; DOI 10.1182/blood-2008-01-133967.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17–producing cells
Hans J. P. M. Koenen1,
Ruben L. Smeets2,
Paul M. Vink2,
Esther van Rijssen1,
Annemieke M. H. Boots2, and
Irma Joosten1
1 Department of Blood Transfusion and Transplantation Immunology, Radboud University Nijmegen Medical Centre, Nijmegen; and
2 Department of Pharmacology, NV Organon, Oss, The Netherlands
The effector T-cell lineage shows great plasticity. Th17 cells are acknowledged to be instrumental in the response against microbial infection, but are also associated with autoimmune inflammatory processes. Here, we report that human regulatory T cells (CD4posCD25highFoxp3posCD127negCD27pos) can differentiate into IL-17–producing cells, when stimulated by allogeneic antigen-presenting cells, especially monocytes, in the presence of rhIL-2/rhIL-15. These regulatory T cell (Treg)–derived IL-17–producing cells showed high expression of the Th17-related transcription factor ROR t and were positively identified by CCR6 expression. This differentiation process was enhanced by exogenous IL-1β, IL-23, and IL-21, whereas IL-6 or TGFβ did not affect the emergence of IL-17–producing cells. The addition of IL-1 receptor antagonist (IL-1Ra), but not anti–IL-23 antibody, reduced IL-17–producing cell numbers. When an histone deacetylase (HDAC) inhibitor trichostatin A (TSA) was evaluated, we found a profound negative effect on the emergence of IL-17–producing cells from Tregs, implying that Treg differentiation into IL-17–producing cells depends on histone/protein deacetylase activity. Thus, the data suggest that epigenetic modification underlies the phenomenon of Treg plasticity here described.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Fletcher, R. Lonergan, L. Costelloe, K. Kinsella, B. Moran, C. O'Farrelly, N. Tubridy, and K. H. G. Mills
CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
J. Immunol.,
December 1, 2009;
183(11):
7602 - 7610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C.-H. Kwan, L.-S. Tam, K.-B. Lai, F. M.-M. Lai, E. K.-M. Li, G. Wang, K.-M. Chow, P. K.-T. Li, and C.-C. Szeto
The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus
Rheumatology,
December 1, 2009;
48(12):
1491 - 1497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P. Wright, C. A. Notley, S.-A. Xue, G. M. Bendle, A. Holler, T. N. Schumacher, M. R. Ehrenstein, and H. J. Stauss
Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis
PNAS,
November 10, 2009;
106(45):
19078 - 19083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. De Serres, M. H. Sayegh, and N. Najafian
Immunosuppressive Drugs and Tregs: A Critical Evaluation!
Clin. J. Am. Soc. Nephrol.,
October 1, 2009;
4(10):
1661 - 1669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Chen, J. C. Delgado, P. E. Jensen, and X. Chen
Direct Expansion of Human Allospecific FoxP3+CD4+ Regulatory T Cells with Allogeneic B Cells for Therapeutic Application
J. Immunol.,
September 15, 2009;
183(6):
4094 - 4102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, T. W. J. Huizinga, and R. E. M. Toes
De Novo Generation and Enhanced Suppression of Human CD4+CD25+ Regulatory T Cells by Retinoic Acid
J. Immunol.,
September 15, 2009;
183(6):
4119 - 4126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zuber, A. Brodin-Sartorius, N. Lapidus, N. Patey, M. Tosolini, S. Candon, M. Rabant, R. Snanoudj, C. Panterne, E. Thervet, et al.
FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis
Nephrol. Dial. Transplant.,
September 3, 2009;
(2009)
gfp435v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. OLIVITO, G. SIMONINI, S. CIULLINI, M. MORIONDO, L. BETTI, E. GAMBINERI, L. CANTARINI, M. DE MARTINO, C. AZZARI, and R. CIMAZ
Th17 Transcription Factor RORC2 Is Inversely Correlated with FOXP3 Expression in the Joints of Children with Juvenile Idiopathic Arthritis
J Rheumatol,
September 1, 2009;
36(9):
2017 - 2024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Gounaris, N. R. Blatner, K. Dennis, F. Magnusson, M. F. Gurish, T. B. Strom, P. Beckhove, F. Gounari, and K. Khazaie
T-Regulatory Cells Shift from a Protective Anti-Inflammatory to a Cancer-Promoting Proinflammatory Phenotype in Polyposis
Cancer Res.,
July 1, 2009;
69(13):
5490 - 5497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-Z. Yang, A. J. Novak, S. C. Ziesmer, T. E. Witzig, and S. M. Ansell
Malignant B Cells Skew the Balance of Regulatory T Cells and TH17 Cells in B-Cell Non-Hodgkin's Lymphoma
Cancer Res.,
July 1, 2009;
69(13):
5522 - 5530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kotsianidis, E. Nakou, I. Bouchliou, A. Tzouvelekis, E. Spanoudakis, P. Steiropoulos, I. Sotiriou, V. Aidinis, D. Margaritis, C. Tsatalas, et al.
Global Impairment of CD4+CD25+FOXP3+ Regulatory T Cells in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
June 15, 2009;
179(12):
1121 - 1130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Sharma, D.-Y. Hou, Y. Liu, P. A. Koni, R. Metz, P. Chandler, A. L. Mellor, Y. He, and D. H. Munn
Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes
Blood,
June 11, 2009;
113(24):
6102 - 6111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nistala and L. R. Wedderburn
Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis
Rheumatology,
June 1, 2009;
48(6):
602 - 606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ayyoub, F. Deknuydt, I. Raimbaud, C. Dousset, L. Leveque, G. Bioley, and D. Valmori
Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor ROR{gamma}t
PNAS,
May 26, 2009;
106(21):
8635 - 8640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Chen, E. Ahmed, T. Wang, Y. Wang, J. Ochando, A. S. Chong, and M.-L. Alegre
TLR Signals Promote IL-6/IL-17-Dependent Transplant Rejection
J. Immunol.,
May 15, 2009;
182(10):
6217 - 6225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Beriou, C. M. Costantino, C. W. Ashley, L. Yang, V. K. Kuchroo, C. Baecher-Allan, and D. A. Hafler
IL-17-producing human peripheral regulatory T cells retain suppressive function
Blood,
April 30, 2009;
113(18):
4240 - 4249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. G. Evans, N. J. Gullick, S. Kelly, C. Pitzalis, G. M. Lord, B. W. Kirkham, and L. S. Taams
In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses
PNAS,
April 14, 2009;
106(15):
6232 - 6237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bugeon, L. M. Gardner, A. Rose, M. Gentle, and M. J. Dallman
Cutting Edge: Notch Signaling Induces a Distinct Cytokine Profile in Dendritic Cells That Supports T Cell-Mediated Regulation and IL-2-Dependent IL-17 Production
J. Immunol.,
December 15, 2008;
181(12):
8189 - 8193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yamazaki, X. O. Yang, Y. Chung, A. Fukunaga, R. Nurieva, B. Pappu, N. Martin-Orozco, H. S. Kang, L. Ma, A. D. Panopoulos, et al.
CCR6 Regulates the Migration of Inflammatory and Regulatory T Cells
J. Immunol.,
December 15, 2008;
181(12):
8391 - 8401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Flores-Borja, E. C. Jury, C. Mauri, and M. R. Ehrenstein
Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis
PNAS,
December 9, 2008;
105(49):
19396 - 19401.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|